Synchron Company
Synchron is a bioelectronics medicine company that develops neuromodulation solutions for previously-untreatable nervous system conditions.
Investors
Technology:
['BioTech & HealthTech']
Headquarters:
Brooklyn, New York, United States
Funding Status:
Late Stage Venture
Investment Stage:
N/A
Founded Date:
2016-04-01
Number Of Exists:
Series A
Last Funding Type:
Series C
Investors Number:
23.0
Last Funding Date:
2022-12-15
Estimated Revenue:
$50M to $100M
Employee Number:
1-10
Total Funding:
130000000.0
Industry:
Med Tech
Investor Type:
Company